Merck director Mary Ellen Coe acquires stock award
The phantom stock award is designated for 100% cash settlement upon Coe's termination of service, under her elected distribution schedule.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Merck & Co., Inc. director Mary Ellen Coe acquired 206.4552 Phantom Stock units in an award dated September 30, 2026, at a reported price of $145.3100 per share. Her reported Phantom Stock position following the award was 32,419.8658 units; the holdings include shares acquired in dividend reinvestment transactions. The units are to be settled 100% in cash upon termination of service under an elected distribution schedule. Coe also reported direct holdings of 10 shares of Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock F1, F2, F3 | 206.4552 | $145.31 | $30K |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. 1-for-1
- F2. Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
- F3. Holdings include shares acquired in dividend reinvestment transactions.
Key Figures
Key Terms
Phantom Stock financial
Plan for Deferred Payment of Directors' Compensation financial
dividend reinvestment transactions financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many phantom stock units did Mary Ellen Coe acquire in MRK?
How are Mary Ellen Coe's MRK phantom stock units settled?
AI-generated analysis. How Rhea-AI works. Not financial advice.